1Dallas J, Kollef M. VAT vs VAP:are we heading toward clarity or confusion? Chest,2009,135:252-255.
2Nseir S, Di Pompeo G, Prounier P, et al. Nosoeomial tracheobrochitis in mechanically ventilated patients: incidence, aetiology and outcome. Eur Respir J,2002,20:1483-1489.
3Dallas J, Skrupky L, Nurelign A, et al. Ventilator-associated trancheobronchitis in a mixed suigical and medical ICU population. Chest, 2011,139 : 513-518.
4Malacarne P, Langer M, Nascimben E, et al. Building a continuous multicenter infections surveillance system in the intensive care unit : finding from initial date set of 9493 patients from 71 Italian intensive care units. Criti Care Med,2008,36: 1105-1113.
5Martin-Loeches I, Pobo A. What is new in ventilator-associate tracheobronchititis?. Clin Pulm Med,2010,17 : 117-121.
9Nseir S, Favory R, Jozefowize E, et al. Antimicrobioal treatment for ventilator-associted tracheobronchitis: a randomized controlled muticenter study. Crit Care,2008,12 : R62.
10Palmer LB, SmaldoneGC, Chen J J, et al. Aerosolized antibiotics and ventilator-associated tracheobronchititis in the intensive care unit. Crit Care Med,2008,36:2008-2013.
二级参考文献24
1Nseir S,Di Pompeo C,Pronnier P, et al. Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome[J]. Eur Respir J, 2002,20:1483-1489.
2Garner JS , Jarvis WR , Emori TG , et al. CDC definitions for noscomial infections, 1988[J]. Am J Infect Control, 1988,16:128-140.
3Luna CM, Vajacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia[J]. Chest, 1997,111: 676-685.
4Bergmans DC, Bonten MJ, Gaillard CA, et al. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, doublelind, placebo-contrlled study [J]. Am J Respir Crit Care Med,2001,164:382-388.
5Rello J, Ausina V, Castella J, et al. Nosocomial respiratory tract infections in multiple trauma patients. Influence of level of consciousness with implications for therapy [J]. Chest,1992,102 : 525-529.
7Singh N, Rogers P, Atwood CW, et al. Short- course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription[J]. Am J Respir Crit Care Med, 2000,162(2 Pt 1) :505-511.
8Trouillet JL , Vuagnat A , Combes A , et al. Pseudomonas aeruginosa ventilator-associated pneumonia:comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms[J]. Clin Infect Dis, 2002,34 : 1047-1054.
9Lee SO,Kim NJ,Choi SH,et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study[J]. Antimicrob Agents Chemother, 2004,48: 224-228.
10Husni RN,Goldstein LS, Arroliga AC, et al. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients [J]. Chest, 1999, 115 :1378-1382.
